Modulatory effects of 17?-estradiol on acute lung inflammation after total occlusion of the descending aorta in male rats
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | ANUNCIACAO, Lucas Ferreira da | |
dc.contributor.author | SOUSA, Marcelo Nunes de | |
dc.contributor.author | VIDAL-DOS-SANTOS, Marina | |
dc.contributor.author | ARMSTRONG-JR, Roberto | |
dc.contributor.author | MOREIRA, Luiz Felipe Pinho | |
dc.contributor.author | CORREIA, Cristiano Jesus | |
dc.contributor.author | BREITHAUPT-FALOPPA, Ana Cristina | |
dc.date.accessioned | 2022-12-21T13:19:15Z | |
dc.date.available | 2022-12-21T13:19:15Z | |
dc.date.issued | 2022 | |
dc.description.abstract | As a consequence of systemic inflammation caused by ischemia and reperfusion (I/R) due to aortic occlusion, the lungs can exhibit increased microvascular permeability, local release of pro-inflammatory mediators, and leukocyte infiltration. Lung tissue infiltration by activated neutrophils is followed by acute respiratory distress syndrome, which is linked to acute pulmonary microvascular damage, high mortality rates, and organ dysfunction. Previous studies have demonstrated that female sex hormones modulate the inflammatory response and that prophylactic treatment with 178-estradiol (E2) can prevent fatalities and preserve mesenteric perfusion and intestinal integrity after ischemia/reperfusion induced by aortic occlusion. In this study, we focused on the protective effects of estradiol after aortic ischemia/reperfusion by evaluating lung injury and endothelial al-terations. Upon anesthesia and mechanical ventilation, male rats were subjected to aortic occlusion for 20 min, followed by 2 h of reperfusion. In parallel, one group of rats received a single injection of estradiol (280 mu g/kg, i. v.) 30 min before ischemia. We observed increased serum concentrations of IL-18, IL-6 and IL-10 in the I/R rats and E2 was able to reduce them. E2 effects after 2 h of reperfusion resulted mainly in decreasing of edema, iNOS expression and preventing leukocyte infiltration. Overall, our data indicate that estradiol might be a supple-mentary approach to deal with systemic processes and lung deterioration. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Fundacao de Amparo Pesquisa do Estado de Sao Paulo [FAPESP] [2020/11211-6, 2021/07455-0] | |
dc.description.sponsorship | [2018/25759-3] | |
dc.identifier.citation | INTERNATIONAL IMMUNOPHARMACOLOGY, v.113, article ID 109311, 9p, 2022 | |
dc.identifier.doi | 10.1016/j.intimp.2022.109311 | |
dc.identifier.eissn | 1878-1705 | |
dc.identifier.issn | 1567-5769 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/50447 | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | eng |
dc.relation.ispartof | International Immunopharmacology | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright ELSEVIER | eng |
dc.subject | Ischemia and Reperfusion | eng |
dc.subject | 17&beta | eng |
dc.subject | -estradiol | eng |
dc.subject | Lung inflammation | eng |
dc.subject | iNOS | eng |
dc.subject.other | nitric-oxide | eng |
dc.subject.other | intestinal ischemia | eng |
dc.subject.other | pulmonary-edema | eng |
dc.subject.other | estradiol | eng |
dc.subject.other | 17-beta-estradiol | eng |
dc.subject.other | pathogenesis | eng |
dc.subject.other | injury | eng |
dc.subject.other | model | eng |
dc.subject.wos | Immunology | eng |
dc.subject.wos | Pharmacology & Pharmacy | eng |
dc.title | Modulatory effects of 17?-estradiol on acute lung inflammation after total occlusion of the descending aorta in male rats | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 5 | |
hcfmusp.contributor.author-fmusphc | LUCAS FERREIRA DA ANUNCIACAO | |
hcfmusp.contributor.author-fmusphc | MARCELO NUNES DE SOUSA | |
hcfmusp.contributor.author-fmusphc | MARINA VIDAL DOS SANTOS | |
hcfmusp.contributor.author-fmusphc | ROBERTO ARMSTRONG JUNIOR | |
hcfmusp.contributor.author-fmusphc | LUIZ FELIPE PINHO MOREIRA | |
hcfmusp.contributor.author-fmusphc | CRISTIANO DE JESUS CORREIA | |
hcfmusp.contributor.author-fmusphc | ANA CRISTINA BREITHAUPT FALOPPA | |
hcfmusp.description.articlenumber | 109311 | |
hcfmusp.description.volume | 113 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 36252489 | |
hcfmusp.origem.scopus | 2-s2.0-85140274676 | |
hcfmusp.origem.wos | WOS:000878199000001 | |
hcfmusp.publisher.city | AMSTERDAM | eng |
hcfmusp.publisher.country | NETHERLANDS | eng |
hcfmusp.relation.reference | Barocelli E, 2006, NITRIC OXIDE-BIOL CH, V14, P212, DOI 10.1016/j.niox.2005.11.006 | eng |
hcfmusp.relation.reference | Boateng S, 2013, DM-DIS MON, V59, P83, DOI 10.1016/j.disamonth.2012.12.004 | eng |
hcfmusp.relation.reference | Booth EA, 2008, CARDIOVASC TOXICOL, V8, P101, DOI 10.1007/s12012-008-9022-2 | eng |
hcfmusp.relation.reference | Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008 | eng |
hcfmusp.relation.reference | Bown MJ, 2001, EUR J VASC ENDOVASC, V22, P485, DOI 10.1053/ejvs.2001.1522 | eng |
hcfmusp.relation.reference | Breithaupt-Faloppa AC, 2014, SHOCK, V41, P208, DOI 10.1097/SHK.0000000000000092 | eng |
hcfmusp.relation.reference | Cavalcante LP, 2018, INTERACT CARDIOV TH, V26, P196, DOI 10.1093/icvts/ivx314 | eng |
hcfmusp.relation.reference | Cavriani G, 2004, EUR J PHARMACOL, V494, P241, DOI 10.1016/j.ejphar.2004.04.048 | eng |
hcfmusp.relation.reference | Cuzzocrea S, 2000, ENDOCRINOLOGY, V141, P1455, DOI 10.1210/en.141.4.1455 | eng |
hcfmusp.relation.reference | Cuzzocrea S, 2002, SHOCK, V18, P169, DOI 10.1097/00024382-200208000-00014 | eng |
hcfmusp.relation.reference | Dubey RK, 2001, HYPERTENSION, V37, P640, DOI 10.1161/01.HYP.37.2.640 | eng |
hcfmusp.relation.reference | Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025 | eng |
hcfmusp.relation.reference | Fantozzi ET, 2018, J SURG RES, V221, P1, DOI 10.1016/j.jss.2017.07.038 | eng |
hcfmusp.relation.reference | Huertas A, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00745-2017 | eng |
hcfmusp.relation.reference | Iglesias JL, 1998, J SURG RES, V80, P156, DOI 10.1006/jsre.1998.5435 | eng |
hcfmusp.relation.reference | Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90 | eng |
hcfmusp.relation.reference | Kowalczyk A, 2015, ARCH IMMUNOL THER EX, V63, P41, DOI 10.1007/s00005-014-0310-1 | eng |
hcfmusp.relation.reference | Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009 | eng |
hcfmusp.relation.reference | Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7 | eng |
hcfmusp.relation.reference | Moris DN, 2014, INT J CLIN EXP MED, V7, P2402 | eng |
hcfmusp.relation.reference | Peng XQ, 2005, AM J RESP CRIT CARE, V172, P470, DOI 10.1164/rccm.200411-1547OC | eng |
hcfmusp.relation.reference | Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI [10.1586/ers.10.92, 10.1586/ERS.10.92] | eng |
hcfmusp.relation.reference | de Sousa PTR, 2018, J VASC SURG, V67, P597, DOI 10.1016/j.jvs.2016.12.125 | eng |
hcfmusp.relation.reference | Sobral MLP, 2022, EUR J CARDIO-THORAC, V61, P666, DOI 10.1093/ejcts/ezab381 | eng |
hcfmusp.relation.reference | Villar J, 2011, CURR OPIN CRIT CARE, V17, P13, DOI 10.1097/MCC.0b013e32834271fb | eng |
hcfmusp.relation.reference | Zemans RL, 2004, CRIT CARE, V8, P469, DOI 10.1186/cc2906 | eng |
hcfmusp.relation.reference | Zhang ML, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/9921897 | eng |
hcfmusp.relation.reference | Zhang P, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105787 | eng |
hcfmusp.relation.reference | Zhu TB, 2016, CELL PHYSIOL BIOCHEM, V38, P1575, DOI 10.1159/000443098 | eng |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | c75c2685-215a-4b8b-9cbf-734523f608ea | |
relation.isAuthorOfPublication | 46c0ad9a-7fb1-4068-9d67-53bf8a58e60e | |
relation.isAuthorOfPublication | 686fb6bc-5f69-41e1-be4b-20fe936d074e | |
relation.isAuthorOfPublication | a1c98670-cafd-4296-8e62-23e17cc3ae82 | |
relation.isAuthorOfPublication | 82d80256-8c59-4d50-813e-702ac179713d | |
relation.isAuthorOfPublication | fd6721b6-3a47-404f-a2ff-5b6770f85c3d | |
relation.isAuthorOfPublication | c30b994d-83bd-4dd2-9640-3577754e17a0 | |
relation.isAuthorOfPublication.latestForDiscovery | c75c2685-215a-4b8b-9cbf-734523f608ea |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_ANUNCIACAO_Modulatory_effects_of_17estradiol_on_acute_lung_inflammation_2022.PDF
- Tamanho:
- 4.82 MB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)